A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

  1. Schmidt, W.A.
  2. Dasgupta, B.
  3. Sloane, J.
  4. Giannelou, A.
  5. Xu, Y.
  6. Unizony, S.H.
  7. Mackie, S.L.
  8. Gonzalez-Gay, M.A.
  9. Spiera, R.
  10. Warrington, K.J.
  11. Villiger, P.M.
  12. Nivens, M.C.
  13. Akinlade, B.
  14. Lin, Y.
  15. Buttgereit, F.
  16. Stone, J.H.
Journal:
Arthritis Research and Therapy

ISSN: 1478-6362,  1478-6354

Year of publication: 2023

Volume: 25

Issue: 1

Type: Article

DOI: 10.1186/S13075-023-03177-6 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus